|
Market Closed -
London S.E.
11:35:25 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 1,616.00 GBX | -0.74% |
|
-0.49% | +4.26% |
| 08-25 | Citigroup says 'buy' Next, UBS raises Drax | AN |
| 08-21 | Hikma Pharmaceuticals: H1 profitability beat; but needs internal biosimilars for sustained re-rating | ![]() |
| Market Cap | 4.65B 4.01B 3.76B 3.43B 6.47B 445B 6.49B 44.61B 17.41B 225B 17.47B 17.09B 745B | P/E 2026 * |
12x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 6.12B 5.28B 4.95B 4.52B 8.51B 585B 8.53B 58.69B 22.9B 295B 22.99B 22.49B 979B | EV / Sales 2026 * |
1.77x | EV / Sales 2027 * | 1.65x |
| Free-Float |
63.17% | Yield 2026 * |
3.9% | Yield 2027 * | 4.13% |
Last Transcript : Hikma Pharmaceuticals PLC
| 1 day | -0.46% | ||
| 1 week | -0.49% | ||
| Current month | +1.96% | ||
| 1 month | +2.47% | ||
| 3 months | +8.09% | ||
| 6 months | +22.98% | ||
| Current year | +4.26% |
| 1 week | 1,609 | 1,648 | |
| 1 month | 1,563 | 1,755 | |
| Current year | 1,187 | 1,762 | |
| 1 year | 1,187 | 1,865 | |
| 3 years | 1,187 | 2,360 | |
| 5 years | 1,174.5 | 2,625 | |
| 10 years | 814.2 | 2,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 2025-11-30 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 2026-02-25 |
| Chief Tech/Sci/R&D Officer | 64 | 2026-02-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2005-10-13 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 2025-12-14 |
Said Darwazah
CHM | Chairman | 69 | 2014-05-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/1/26 | Sell | Investor Relations Manager | -26,558 | 0.0124% | ||
| 6/1/26 | Fiscal year | Director | 72,763 | 0.0339% | ||
| 6/1/26 | Fiscal year | Director | 20,650 | 0.0096% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.74% | -0.49% | -12.32% | -23.85% | 4.65B | ||
| -0.13% | -6.44% | +60.47% | +112.05% | 1,048B | ||
| +0.85% | -0.81% | +52.77% | +63.15% | 640B | ||
| -1.03% | -3.58% | +22.87% | +73.29% | 456B | ||
| -1.46% | -3.52% | +36.60% | +38.39% | 362B | ||
| -0.72% | -2.06% | +21.34% | +37.92% | 295B | ||
| -1.19% | -0.98% | +0.79% | +12.29% | 255B | ||
| -1.05% | -1.57% | +51.40% | +68.55% | 236B | ||
| +0.08% | -0.22% | -17.16% | -53.76% | 204B | ||
| -2.14% | -0.30% | +29.42% | +89.10% | 185B | ||
| Average | -0.63% | -0.62% | +24.62% | +41.71% | 368.63B | |
| Weighted average by Cap. | -0.44% | -1.92% | +38.36% | +65.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 2.98B 2.8B 2.55B 4.81B 331B 4.83B 33.19B 12.95B 167B 13B 12.72B 554B | 3.6B 3.1B 2.91B 2.66B 5B 344B 5.02B 34.53B 13.47B 174B 13.52B 13.23B 576B |
| Net income | 412M 355M 333M 304M 573M 39.4B 575M 3.95B 1.54B 19.89B 1.55B 1.51B 65.94B | 453M 391M 366M 334M 630M 43.34B 632M 4.35B 1.7B 21.88B 1.7B 1.67B 72.54B |
| Net Debt | 1.47B 1.27B 1.19B 1.08B 2.04B 140B 2.05B 14.08B 5.49B 70.86B 5.51B 5.39B 235B | 1.29B 1.11B 1.05B 954M 1.8B 124B 1.8B 12.4B 4.84B 62.4B 4.86B 4.75B 207B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | GBX 1,616.00 | -0.74% | 436,178 |
| 26-08-27 | GBX 1,628.00 | -0.73% | 445,434 |
| 26-08-26 | GBX 1,640.00 | 0.00% | 862,660 |
| 26-08-25 | GBX 1,640.00 | +0.43% | 349,026 |
| 26-08-24 | GBX 1,633.00 | -0.18% | 680,937 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HIK Stock
Select your edition
All financial news and data tailored to specific country editions



















